Sign up to save your podcasts
Or
Share Transition from CPB to ECMO – How to Manage Anticoagulation Reversal?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Transition from CPB to ECMO – How to Manage Anticoagulation Reversal?
🎙️ Episode 20: Transition from CPB to ECMO – How to Manage Anticoagulation Reversal?
In this episode, Dr. Salman Pervaiz Butt (Head of Perfusion Services, Heart, Vascular and Thoracic Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates) addresses one of the most challenging scenarios in cardiovascular surgery and critical care: anticoagulation reversal during the transition from cardiopulmonary bypass (CPB) to ECMO support.
The webinar explores the risks associated with full or partial heparin reversal, the role of monitoring tools such as TEG, ROTEM, and activated clotting time (ACT), and current clinical strategies to balance thrombotic and bleeding risks. A key discussion highlighting the urgent need for standardized guidelines and multicenter collaboration to support evidence-based decision-making in this critical setting.
View all episodes
By Healthcare Training Experience🎙️ Episode 20: Transition from CPB to ECMO – How to Manage Anticoagulation Reversal?
In this episode, Dr. Salman Pervaiz Butt (Head of Perfusion Services, Heart, Vascular and Thoracic Institute, Cleveland Clinic Abu Dhabi, United Arab Emirates) addresses one of the most challenging scenarios in cardiovascular surgery and critical care: anticoagulation reversal during the transition from cardiopulmonary bypass (CPB) to ECMO support.
The webinar explores the risks associated with full or partial heparin reversal, the role of monitoring tools such as TEG, ROTEM, and activated clotting time (ACT), and current clinical strategies to balance thrombotic and bleeding risks. A key discussion highlighting the urgent need for standardized guidelines and multicenter collaboration to support evidence-based decision-making in this critical setting.